Psychosocial consequences of xylazine and implications for harm reduction services
Introduction: Xylazine, a veterinary tranquilizer not approved for human use, has increasingly contaminated the unregulated drug supply in the United States and is a key driver of an increasingly synthetic, polysubstance overdose crisis. While research has focused on xylazine’s toxicologic and physi...
Saved in:
| Main Authors: | Marina Plesons, William H. Eger, Erika L. Crable, Maia H. Hauschild, Corbin C. McElrath, Cyrus Owens, David W. Forrest, Angela R. Bazzi, Naida De Los Santos, Hansel E. Tookes, Tyler S. Bartholomew |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-09-01
|
| Series: | Drug and Alcohol Dependence Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S277272462500040X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Xylazine prevalence and concentration in the Los Angeles fentanyl market, 2023–2025
by: Joseph Friedman, et al.
Published: (2025-09-01) -
Using RE-AIM to evaluate the implementation of a social marketing and free product distribution project for fentanyl and xylazine test strips in New York State
by: Hilary M. Kirk, et al.
Published: (2025-06-01) -
THE CLINICAL EVALUATION OF THE EFFECT OF XYLAZINE IN PREGNANT BUFFALOEs AND CATTLE
by: M. J. Eesa
Published: (2007-12-01) -
“Anything can happen”: experiences of people using opioids in a xylazine market
by: Megan K. Reed, et al.
Published: (2025-07-01) -
Effects of Xylazin on sedative, analgesic and some liver enzymes in rats
by: Nazlı Halitoğullari, et al.
Published: (2025-04-01)